New Era of Leadership
Sure! Here’s a more concise version of your text:
In today’s fast-changing healthcare landscape, pharmaceutical leadership is entering a new era—driven by innovation, agility, and purpose. Nowhere is this more evident than in Medical Affairs, where the role is evolving from scientific support to strategic leadership focused on patient value, collaboration, and real-world evidence. In this special series, Bagrat Lalayan speaks with top industry leaders about navigating global challenges, embracing digital transformation, and leading with vision—while keeping patient outcomes at the center of it all.
AI and the HCP Experience: Implications for Medical Affairs
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
The Psychology of Impact in Pharma
Here, we explore the application of the SCARF (status, certainty, autonomy, relatedness, and fairness) model, learned helplessness, and locus of control to the assessment of impact in the pharmaceutical industry and describe approaches by which hesitancy can be overcome.
Are we truly measuring what matters in Medical Affairs?
This article summarizes an engaging Roundtable discussion, emphasizing the transformative influence of metrics, data, and technology, particularly Artificial Intelligence (AI), on the strategic role of Medical Affairs.
The Future is Agentic: Unlocking AI’s Potential for Medical Insights
Discover how Agnetic is harnessing AI to revolutionize healthcare, unlocking powerful medical insights for better, faster, and more personalized care.
Operationalizing Medical Strategy: A Success Story in Demonstrating Value and Impact
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
A Rapidly Changing Regulatory Landscape: What Medical Affairs Leaders Should Know
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.